![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright Koo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. An Obligatory Role of Mind Bomb-1 in Notch Signaling of Mammalian Development 1Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, Kyungbuk, South Korea 2Department of Biology, Chungnam National University, Daejeon, South Korea 3Howard Hughes Medical Institute, Department of Physiology, University of California at San Francisco, San Francisco, California, United States of America 4Howard Hughes Medical Institute, Department of Biochemistry, University of California at San Francisco, San Francisco, California, United States of America Francois Schweisguth, Academic Editor Ecole Normale Superieure, France #Contributed equally. * To whom correspondence should be addressed. E-mail: ykong/at/postech.ac.kr Conceived and designed the experiments: YJ YK BK MY KY CK PS. Performed the experiments: BK MY KY SI YK. Analyzed the data: YK BK MY KY SI YK. Contributed reagents/materials/analysis tools: YJ. Wrote the paper: YK BK MY KY SI YK. Received August 20, 2007; Accepted October 31, 2007. This article has been cited by other articles in PMC.Abstract Background The Notch signaling pathway is an evolutionarily conserved intercellular signaling module essential for cell fate specification that requires endocytosis of Notch ligands. Structurally distinct E3 ubiquitin ligases, Neuralized (Neur) and Mind bomb (Mib), cooperatively regulate the endocytosis of Notch ligands in Drosophila. However, the respective roles of the mammalian E3 ubiquitin ligases, Neur1, Neur2, Mib1, and Mib2, in mammalian development are poorly understood. Methodology/Principal Findings Through extensive use of mammalian genetics, here we show that Neur1 and Neur2 double mutants and Mib2−/− mice were viable and grossly normal. In contrast, conditional inactivation of Mib1 in various tissues revealed the representative Notch phenotypes: defects of arterial specification as deltalike4 mutants, abnormal cerebellum and skin development as jagged1 conditional mutants, and syndactylism as jagged2 mutants. Conclusions/Significance Our data provide the first evidence that Mib1 is essential for Jagged as well as Deltalike ligand-mediated Notch signaling in mammalian development, while Neur1, Neur2, and Mib2 are dispensable. Introduction The Notch signaling pathway is an evolutionarily conserved signaling module from nematode to human, which plays essential roles in pattern formation and cell fate determination through local cell-cell interactions [1]. Notch signaling is initiated by the interaction of the Notch receptors with their ligands, Delta [Deltalike (Dll) in mammals] and Serrate [Jagged (Jag) in mammals] [2], [3]. These interactions induce two sequential proteolytic cleavages of Notch receptor (S2 and S3 cleavages), and generate a soluble intracellular domain (Nicd) that translocates to the nucleus to form a transcriptional activator complex with Su(H)/CBF1/RBP-J. This complex activates the anti-neurogenic basic helix-loop-helix (bHLH) repressors. Although much is known about Notch signal transduction after the receptor undergoes the ligand-dependent S2 cleavage, the mechanism by which the Notch ligands engage Notch receptors and trigger their cleavage is less understood. It has been suggested that the endocytosis of Notch ligands in the signal-sending cells is required for the effective activation of Notch signaling [4]. Two structurally distinct E3 ubiquitin ligases, Neuralized (Neur) and Mind bomb (Mib), regulate the endocytosis of the Notch ligand, Delta, in Drosophila and zebrafish, respectively [5]–[9]. Both proteins have been shown to interact with Delta and to promote its ubiquitination, endocytosis, and signaling. Interestingly, loss-of-function mutations in zebrafish mib and Drosophila neur cause similar expansions of the neural precursors, at the expense of the epidermis, through the loss of lateral inhibition [6], [9]. Since Mib and Neur share biochemical functions and their mutants show similar phenotypes, these two proteins were suggested to be functional homologues between species [10]. However, since the homologues of Mib and Neur are evolutionarily conserved, respectively, it has been suggested that a more complex interplay may exist between these E3 ubiquitin ligases and the endocytosis of Delta. There are one neur (dneur) gene and two mib (dmib1 and dmib2) homologue genes in Drosophila. Both dMib1 and dNeur are essential for a subset of the developmental events that are regulated by Notch signaling [10], [11]. dmib1 mutants showed defects in wing margin specification, leg segmentation, and vein determination, while dneur mutants displayed increased numbers of neuroblasts and sensory organ precursors [9], [10]. Although dMib1 and dNeur regulate both Delta and Serrate [12], it has been suggested that dMib1 and dNeur are required for a distinct subset of Notch signaling events, primarily because of their differential expression patterns [10]. Interestingly, ectopic overexpression of dMib1 and dNeur in each other's mutants revealed their complementary functions, suggesting that they have similar molecular activities in Drosophila [10], [11]. Likewise, each mutant shows specific phenotypes, but also has a redundant phenotype, depending on the expression profiles. In fact, the dneur and dmib double mutant fly showed a complete block of lateral inhibition in sensory organ precursors [12]. Thus, in Drosophila, both the Delta and Serrate ligands require E3 ubiquitin ligases for their activity, and the requirement of dMib and dNeur appears to depend on the context. In vertebrates, there are two Mib homologues, Mib1 and Mib2, and two Neur homologues, Neur1 and Neur2 [5], [6], [13]–[15]. All of them are implicated in the endocytosis of Notch ligands [5], [6], [13]–[15]. Mib1 is abundantly expressed in both embryos and adult tissues, while Mib2 is highly expressed in adult tissues, but only slightly in embryos [14]. Both Neur1 and Neur2 are expressed in the brain, but also specifically expressed in skeletal muscle and kidney, respectively [15]–[17]. Their differential expression profiles suggest that these E3 ligases may have redundant and/or specific functions in distinct contexts. Loss-of-function genetic studies revealed that unlike the Drosophila neur mutants, Neur1−/− mice have no defect in neurogenesis and embryonic development, possibly due to a functional overlap with Neur2 [16], [17]. In contrast, Mib1−/− mice exhibited a neurogenic phenotype as well as pleiotropic Notch-related defects on embryonic day 9.5, suggesting the possible obligatory role of Mib1 in the regulation of multiple Dll and Jag ligands in mammalian development [13]. However, genetic evidence for these matters is still lacking, and other E3 ligases might have compensatory roles in the regulation of Notch ligands [14], [15]. To elucidate the interplay between the four E3 ubiquitin ligases and the Notch ligands in mammalian development, more comprehensive genetic studies of these four E3 ubiquitin ligases are required in a single organism. There are five canonical Notch ligands, Dll1, Dll3, Dll4, Jag1, and Jag2 in mammals. Since Dll3 has no lysine residue for ubiquitin ligation [18], the others, Dll1, Dll4, Jag1, and Jag2, would be regulated by E3 ubiquitin ligases. The specific functions of each ligand have been identified through many genetic studies. Dll1 is required in somitogenesis and marginal zone B cell development, and Dll4 regulates arteriogenesis and angiogenesis [19]–[21]. Jag1 conditional knockout mice revealed its role in cerebellum development and hair maintenance [22], [23]. Jag2 mutant mice are well known to have syndactylism [24], [25]. These mutant studies have suggested the specific roles of each ligand in various Notch-mediated fate decisions. However, which E3 ligases are implicated in the distinct contexts regulated by each Notch ligand in mammalian development is largely unknown. To establish the respective roles of these four E3 ubiquitin ligases in the various contexts of a single organism, we have generated Neur2−/−, Neur1−/−;Neur2−/− (Neur1&2DKO), Mib2−/−, and Mib1 conditional mutant (Mib1f/f) mice. Both the Neur2−/− and Mib2−/− mice are viable, fertile, and grossly normal. Surprisingly, Neur1&2DKO mice are also viable and have no recognizable developmental defect, demonstrating the dispensable role of Neur1 and Neur2 in mammalian development. In contrast, the conditional inactivation of Mib1 in the endothelium, skin epithelium, cerebellum, and apical ectodermal ridge faithfully showed the representative Notch phenotypes, such as the defects in arterial specification, and cerebellar and skin development exhibited by Dll4, and Jag1 mutant mice, respectively, and the syndactylism shown in Jag2−/− mice. Our results clearly demonstrate the obligatory role of Mib1 in the regulation of Notch ligands during mammalian development. Results Generation of Neur2−/− mice The murine Neur2 locus comprises 5 exons. The IRES-lacZ-puro cassette was fused to exon 2, with the deletion of exon 3 (Figure 1A
Both Neur1 and Neur2 are dispensable for mammalian development In Drosophila, there is one dNeur that is essentially required for Notch signaling in lateral inhibition [9]. In vertebrates, however, there are two Neur homologues, Neur1 and Neur2, which have similar degrees of homology to dNeur [15]. The mutant mice with a disruption in either Neur1 or Neur2 were healthy and had few Notch-related phenotypes [16], [17], suggesting possible compensation by each other. To test this possibility, we generated Neur1&2DKO mice. Surprisingly and unexpectedly, the Neur1&2DKO mice were born at the expected Mendelian ratios from intercrosses of Neur1&2 double heterozygous mice (Figure 1D Mib2 is dispensable in mammalian development Both Mib1 and Mib2 have similar biochemical activity to Notch ligand(s), and Mib2 can rescue the Notch phenotypes of zebrafish mib1 mutants [14]. In addition, Mib2 is highly expressed in adult tissues, but only slightly in embryos [14]. Thus, we speculated that Mib2 might function in adulthood, whereas Mib1 has an obligatory role in embryos. To test this possibility, we generated Mib2−/− mice. The murine Mib2 locus comprises 21 exons. The IRES-lacZ-puro cassette was inserted within exon 5, and the remaining region from exon 5 to exon 15 was replaced with the IRES-lacZ-puro cassette (Figure 2A
Heterozygous intercrosses produced their offspring at the predicted Mendelian ratio, and the Mib2−/− mice did not show any recognizable differences in growth, body weight, and health up to 12 months, as compared to the control littermates. In addition, the mutant brains in embryos as well as in adults were indistinguishable in both size and appearance from their control littermates (not shown). A histological analysis of the Mib2−/− brains revealed no detectable abnormalities at both the embryonic and adult stages (Figure 2E To reveal the effects of the loss of Mib2 in more sensitized condition, we crossed Mib1+/− mice with Mib2−/− mice to generate Mib1+/−;Mib2−/− and Mib1−/−;Mib2−/− mice. Although Mib1+/−;Mib2−/− mice have only one Mib homologue, these mice are also viable and have no recognizable abnormalities, suggesting that a single allele of Mib1 gene is enough to regulate the mammalian Notch signaling (not shown). However, Mib1−/−;Mib2−/− mice showed embryonic lethality with similar defects with Mib1−/−;Mib2+/− or Mib1−/− mice (Figure 2F Generation of Mib1 conditional knockout mice Among the four E3 ubiquitin ligases for Notch ligands in mammals, only the Mib1−/− mice showed severe Notch-related phenotypes and early embryonic lethality (~E10.5) [13], while the Neur1&2DKO and Mib2−/− mice did not show any obvious Notch-related phenotype until adulthood. Notch signaling is implicated in various cell fate decisions, not only in early embryogenesis but also in late organogenesis and the postnatal stages. Moreover, genetic studies of Notch ligands revealed the specific roles of each ligand in various Notch-mediated fate decisions. However, it is not known which E3 ligase is involved in these Notch signaling events. To clarify this issue, we generated Mib1 conditional knockout mice carrying two loxP sites between exons 1 and 2 and between exons 3 and 4 (Figure S1). The homozygous mice (Mib1f/f) were generated as described for the Neur2−/− mice. The Mib1f/f mice were fully fertile and had no abnormalities. Moreover, Mib1f/− mice also had no abnormalities. To verify the generation of Mib1f/f mice, the null mice (Mib1Δ/Δ) were generated using protamine-cre transgenic mice that produce a germ line deletion of the loxP-floxed region. These Mib1Δ/Δ mice showed the same phenotypes as the Mib1−/− mice (not shown) [13], indicating that the Mib1 conditional allele is fully functional and became a null allele by the Cre recombinase. Conditional inactivation of Mib1 in endothelial cells generates a Dll4 mutant phenotype Dll4 is responsible for arterial cell specification in vascular development [19], [20], [27]. Mib1 interacts with Dll4 and induces its endocytosis [13]. Therefore, we examined whether Mib1 is required for vascular development. The Mib1f/f mice were bred with Tie2-cre transgenic mice, which express Cre recombinase under the control of the Tie2 promoter [28]. The Tie2-cre;Mib1f/f mice were embryonic lethal around E11.5. Therefore, the Tie2-cre;Mib1f/f embryos were dissected at E7.5-E10.5. At E8.5, there were no obvious differences between the wild-type and Tie2-cre;Mib1f/f embryos (not shown). Between E9.5 and E10.5, however, the Tie2-cre;Mib1f/f embryos exhibited characteristic vascular remodeling defects, such as a mottled avascular yolk sac, growth retardation, and pericardial effusion (Figure 3A, B
We further examined whether arterial cell fate is also impaired in Tie2-cre;Mib1f/f embryos. EphrinB2 is one of the earliest arterial-specific endothelial cell markers [29]. In wild-type embryos, ephrinB2 was normally expressed in arteries, but not in Tie2-cre;Mib1f/f embryos, whereas its expression was retained in other tissues (Figure 3J Conditional inactivation of Mib1 in skin epithelial cells generates a Jag1 mutant phenotype Notch signaling plays important roles in epidermal differentiation and hair follicle maintenance [31], [32]. Jag1 is expressed in the differentiated interfollicular epidermis (IFE), outer root sheath (ORS), pre-cortex, and matrix of hair follicles, and a genetic study revealed that Jag1 is the Notch ligand responsible for the maintenance of hair [22]. Since Mib1 is also expressed in IFE and hair follicles and regulates the endocytosis of Jag1 [13], [14], we examined whether conditional inactivation of Mib1 in the skin also reproduces the Jag1 mutant phenotype in the skin. We bred Mib1f/f mice with Msx2-cre transgenic mice, in which the Cre recombinase is active not only in the apical ectodermal ridge at E11.5 but also in the dorsal ectoderm of early embryos and the matrix of hair follicles after birth [31], [33]. The Msx2-cre;Mib1f/f mice were smaller than their littermate controls and progressively lost their hair from the dorsal midline. They became completely bald at about 4 weeks after birth (Figure 4A
At postnatal day 28 (P28), the back skin of the wild-type contained hair follicles in an anagen state (Figure 4B Conditional inactivation of Mib1 in cerebellum generates a Jag1 mutant phenotype Previous analyses of Notch1, Numb and Jag1 conditional mutant mice revealed that Notch signaling is important in cerebellar development [23], [34], [35]. Loss of Jag1 results in delayed granule cell migration, potentially because of the mis-organized Bergmann glial fibers [23]. In order to examine whether Mib1 is required for cerebellar development, we bred Mib1f/f mice with hGFAP-cre transgenic mice, in which Cre recombinase is expressed in the Bergmann glia and granule cells, but not in the Purkinje cells, in the cerebellum [36]. A western blot analysis of a cerebellar lysate confirmed the ablation of Mib1 in these mice (Figure 5A
The hGFAP-cre;Mib1f/f mice were smaller than the wild-type littermates, and died between 2 to 4 months. While the cerebellum sizes were indistinguishable at P4, reductions in both the cerebellum size and foliation were recognizable in the mutant mice from P9 (Figure 5B A previous study suggested that the delayed migration of granule cells in the En2-cre;Jag1f/f conditional knockout cerebellum might be due to the mis-organized Bergmann glial fibers [23]. When we examined the integrity of the Bergmann glial fiber in the developing cerebellum with the glial markers, GFAP and BLBP, the Bergmann glial processes were severely disorganized in the P15 hGFAP-cre;Mib1f/f cerebellum, while the wild-type cerebellum showed radially organized processes of the Bergmann glia (Figure 5O–R Conditional inactivation of Mib1 in the apical ectodermal ridge generates a Jag2 mutant phenotype Syndactyly (digit fusions) is a well known Jag2 mutant phenotype [24], [25]. Especially, the loss of Notch signaling in the apical ectodermal ridge (AER) of the embryonic limb bud causes this phenotype [38]. Jag2 is expressed in the AER from E10.5, and its mutant mice show severe syndactylism that is equivalent to the phenotypes of Notch1&2DKO and presenilin1&2DKO mice, suggesting the exclusive role of Jag2 in this process. Interestingly, Mib1 is also highly expressed in the AER and in the underlying mesenchyme at E10.5 (Figure 6A
To examine whether Msx2-cre;Mib1f/f embryos have similar molecular changes in the developing limb bud as in other Notch-related mutants, we analyzed the expression patterns of Fgf8 (fibroblast growth factor 8; AER marker) and Bmp2 (bone morphogenetic protein 2; interdigital cell marker at E13.5). Other notch-related mutant mice exhibit a hyperplastic AER and an expanded Fgf8 expression domain [24], [25], [38]. As expected, the Fgf8 expression domain in the newly formed AER of the hind limb bud was expanded in the Msx2-cre;Mib1f/f embryos, as compared to the wild-type (Figure 6J, K Discussion Many E3 ubiquitin ligases are involved in regulating the Notch signaling pathway [41]. They are divided into two groups, one that ubiquitinates Notch receptors and the other that regulates Notch ligands. Two kinds of E3 ubiquitin ligases, Neur and Mib1, are important for the endocytosis of Notch ligands in Drosophila and zebrafish/mice, respectively [5]–[8], [13]. In Drosophila, depending on the developmental context, either dMib1 or dNeur is required for the activation of two Notch ligands, Delta and Serrate [10]–[12]. In mammals, there are two Mib homologues, Mib1 and Mib2, and two Neur homologues, Neur1 and Neur2, along with five Notch ligands, Dll1, Dll3, Dll4, Jag1, and Jag2, in the genome. However, the requirement of each E3 ubiquitin ligase in the developmental contexts where Notch signaling is active was largely unknown. In this report, we have analyzed the phenotypes of Neur2−/−, Neur1&2DKO, Mib2−/−, and Mib1f/f mice expressing the Cre enzyme by various promoters. Unexpectedly, only the Mib1 conditional mutant mice faithfully exhibited the various Notch phenotypes representating each of the Dll4, Jag1, and Jag2 mutant mice. Collectively, our extensive genetic studies reveal that Mib1 is the E3 ubiquitin ligase responsible for the regulation of Notch ligands in mammalian development. An obligatory role of Mib1 in mammalian development In Drosophila, dneur mutants were initially identified by the loss of lateral inhibition in neurogenesis, which results in the overproduction of neuroblasts at the expense of the epidermoblast [9]. Although dMib1 and dNeur have similar functions and are exchangeable in some developmental contexts, the endogenous level of dNeur is important for the lateral inhibition that inhibits the neuronal fate in the epidermis [10], [11]. Moreover, the overexperssion of dMib1 in dneur mutant Drosophila cannot rescue the cuticular neurogenic phenotype of dneur mutant embryos, indicating a non-redundant function of Neur in this context [10]. Consistently, dneur is expressed throughout the ectoderm during neuronal cell fate specification [42]. Likewise, both murine Neur1 and Neur2, which have a similar phylogenic distance from dneur, are expressed in the embryonic and adult brain [15]. In this study, however, the Neur1&2DKO mice did not show any obvious developmental defects in brain development and their other tissues were grossly normal, demonstrating that both Neur1 and Neur2 are dispensable in the neurogenesis where Notch-mediated lateral inhibition controls the number of neurons in mammalian development. Although we did not observe an obvious Notch phenotype in the Neur1&2DKO mice, we cannot exclude a possible role in the fine regulation of Notch ligands. Since Neur1−/− mice have olfactory discrimination defects and ethanol hypersensitivity [16], the Neur1&2DKO mice could have more severe defects in their behavior, although they did not exhibit a prominent developmental defect. In contrast, we previously reported that Mib1−/− mice exhibit a severe neurogenic phenotype in the developing brain and neural tube in E9.5 embryos [13], demonstrating that Mib1 is essential for the lateral inhibition of embryonic neurogenesis, and the endogenous levels of both Neur1 and Neur2 cannot compensate for the loss of Mib1. In addition, the endocytosis of Dll1 was completely impaired in the Mib1−/− mice, suggesting that Mib1 is essentially required for Dll1 endocytosis [13]. Consistently, the overexpression of either mouse Neur1 or Neur2 alone does not promote the endocytosis of Xenopus Delta in Cos7 cells, while mouse Mib1 does [15]. Furthermore, zebrafish mib1 mutants also showed DeltaD accumulation in the plasma membrane and a neurogenic phenotype that is a representative Notch defect of lateral inhibition in neurogenesis [6]. Consistent with these findings, the overexpression of mouse Neur2 in the zebrafish mib1 mutants could not reduce the increased number of zath1-positive hair cells, which results from the failure of lateral inhibition in the mechanosensory organs [15]. Abundant evidence suggested that Mib1, but not Neur1/2, might be the E3 ubiquitin ligase that regulates Notch ligands in mammalian development. Previously reported Mib1−/− mice exhibited multiple defects in neurogenesis, somitogenesis, vasculogenesis, and cardiogenesis [13]. The developmental defects shown in Mib1−/− mice might be caused by the loss of Dll1 (neurogenesis, somitogenesis), Dll4, (vasculogenesis, cardiogenesis) signaling [13]. In this study, the Tie2-cre;Mib1f/f embryos also exhibited the vascular defects characteristic of Dll4+/− and Dll4−/− mice, such as defective remodeling and impaired arterial fate specification. Since the Dll4-Notch1 signaling pathway is essential for arterial fate specification, our data strongly suggest that Mib1 is the E3 ligase that regulates Dll4 activity in endothelial cells. Moreover, conditional inactivation of Mib1 in hematopoietic system also exhibited the characteristic phenotype of Dll1 mutants, the defect in the formation of marginal zone B cells (Song et al., our unpublished observation). In addition to the regulation of Dll ligands, our data suggested that Mib1 is also the E3 ubiquitin ligase that regulates Jag ligands in mammalian development. The hGFAP-cre;Mib1f/f mice exhibited delayed granule cell migration in the cerebellum. In addition, the Msx2-cre;Mib1f/f mice showed hair follicle loss and epidermal cyst formation in the skin. These are both representative phenotypes of Jag1 conditional knockout mice [22], [23]. Furthermore, the Msx2-cre;Mib1f/f mice also showed syndactylism, which is a well known Notch phenotype of Jag2 null mice [24], [25]. Among the five canonical Notch ligands in mammals, Dll3 lacks a lysine residue in the cytoplasmic domain for ubiquitination, suggesting that it might not be a direct substrate of the E3 ubiquitin ligases. Except for Dll3, the other four Notch ligands, Dll1, Dll4, Jag1, and Jag2, should be regulated by E3 ligases for their endocytosis, because a plethora of evidence suggested that ligand endocytosis in the signal-sending cells is required for proper Notch activation in the signal-receiving cells, and that E3 ligases regulate their endocytosis. While Neur1&2DKO and Mib2−/− mice did not show any obvious Notch phenotype, the Mib1−/− mice in the previous study and the Mib1 conditional knockout mice in various tissues in the present study clearly displayed the representative Notch phenotypes of each Notch ligand-null strain [13]. Thus, we concluded that Mib1, but not Neur1/2, plays an exclusive role in mammalian development, by potentially regulating the endocytosis of Jag ligands as well as Dll ligands. Evolutionary flux in the regulation of Notch ligands by E3 ligases The Notch signaling pathway is evolutionarily conserved from nematode to human. In terms of the requirement of E3 ligase for Notch ligand endocytosis, however, evolutional divergence may exist. In C. elegans, in which the Notch signaling pathway is conserved as in Drosophila and vertebrates, there is a neur homologue, but no mib homologue. However, in contrast to the strict requirement of Notch ligand endocytosis in Drosophila, DSL ligand endocytosis does not seem to be conserved in C. elegans. The extracellular domains of DSL ligands can fully rescue the lag-2 mutant and activate Notch signaling, while the intracellular domain-deleted mutants of Delta have a dominant-negative activity in Drosophila [43]–[45]. In zebrafish, mib1 mutants accumulate DeltaD in the plasma membrane, and in a transplantation experiment, mib1 null cells could not activate Notch signaling in the adjacent signal-receiving cells, indicating a strong requirement for ligand endocytosis in the Notch activation in zebrafish as well [6]. Consistently, Mib1−/− mice, in which the endocytosis of Dll1 was completely impaired and Dll1 accumulated in the plasma membrane, exhibit reduced expression of Notch target genes and loss of N1icd generation [13]. Furthermore, Mib1−/− cells cannot activate Notch signaling in a co-culture system with C2C12-Notch1 cells containing a CBF-Luciferase reporter gene [13]. Collectively, the requirement of E3 ligase in Notch ligand endocytosis appears to be well conserved from Drosophila to mammals. In the regulation of Notch ligand endocytosis, however, two structurally distinct E3 ligases, Mib and Neur, might have evolved differently. In Drosophila, both Notch ligands, Delta and Serrate, require an E3 ubiquitin ligase, either dMib or dNeur, for their activity in Notch-mediated cell fate decisions dependent on expression patterns [10]–[12]. In mammals, however, Mib1 is essential for Notch-mediated cell fate decisions in all contexts of mammalian development examined in this study and the previous studies [13]. In contrast, the Neur1−/− mice generated by two independent groups did not show any apparent developmental Notch defects [16], [17]. In this study, the Neur2−/− and Neur1&2DKO mice also were grossly healthy without any observable abnormality. Consistent with this finding, Neur1 and Neur2 do not induce endocytosis of Notch ligands in various cells, including Cos7 cells [15], whereas Mib1 and Mib2 readily do [13], [14]. Although Xenopus Neur1 has been suggested to regulate Notch ligands in lateral inhibition, as revealed by an overexpression experiment [5], the loss-of-function studies using zebrafish mib1 mutants and Mib1−/− and Mib1f/f mice indicated that Mib1 is required for various Notch-dependent cell fate decisions [6], [13]. Thus, the two structurally distinct E3 ligases, Mib and Neur, might have evolved differently in the Notch signaling pathway during evolution, especially in insects and vertebrates. There are two Mib homologues, Mib1 and Mib2, from Drosophila to human [14]. As described above, Mib1 is functionally well conserved from Drosophila to mice. However, a substantial disparity exists, at least between zebrafish and mice. The zebrafish mib1ta52b mutants accumulated DeltaD in the plasma membrane and have various Notch mutant phenotypes, affecting neurogenesis, somitogenesis, vasculogenesis, and hematopoiesis. Interestingly, overexpression of Mib2, but not Neur1 and Neur2, rescues the neurogenic and vasculogenic defects in these mutants [14], [15], suggesting that Mib2 can regulate Notch ligands in these contexts. In fact, a recent comparative analysis of zebrafish mib1 mutants with an antimorphic allele, mib1ta52b, and a null allele, mib1tfi91 suggested that Mib1 and Mib2 might have a redundant role in Notch signaling [46]. The mib1tfi91 mutants exhibited no obvious somite defects, while the mib1ta52b mutants have a severe somite phenotype, suggesting that the antimorphic mib1ta52b mutant with a mutation in the RING domain might suppress the Mib2 function in the mib1ta52b mutants, and that both Mib1 and Mib2 might function in somite formation. In contrast, two independently generated Mib1−/− mouse strains [13], [47] and the Mib1Δ/Δ mice conditionally deleted by the protamine-cre system in this study display defects in somitogenesis, with only a few anterior somites with irregular shapes. Thus, the dependency of Mib1 and Mib2 in species might have evolved differently. We cannot completely exclude the possibility that other E3 ligases, Mib2, Neur1, and Neur2, might play a critical role in the fine regulation of Notch signaling, which could not be recognized in the present assay systems that have been developed in order to elucidate Notch contexts, because of technical limitations. However, the inactivation of Mib1 faithfully reproduced well-known Notch phenotypes, such as defects in neurogenesis, somitogenesis, vasculogenesis, hematopoiesis, skin morphogenesis, etc., in all contexts of mammalian development examined, without exception. Thus, our study strongly suggests that Mib1 is the core E3 ubiquitin ligase that regulates Notch ligands. This provides the first genetic evidence that Mib1 is required for the Notch-mediated cell fate decisions in a single organism, especially in mammals. Methods Mice The Mib1f/f, Mib2−/−, and Neur2−/− mice were generated through the germ-line transmission of chimeric C57BL/6 mice with targeted E14K ES cells, and the Neur1−/− mice were previously generated [16]. The transgenic mouse lines, Tie2-cre, and hGFAP-cre, were purchased from Jackson Laboratories, and the Msx2-cre mouse line was kindly provided by B. Harfe and G.R. Martin. All of the mice were maintained in our animal colony under institutional guidelines. Southern and northern blot analyses and RT-PCR analysis For the Southern blot analysis, genomic DNA from ES cells or mouse tail tip cells was digested by the appropriate restriction enzymes and fractionate by agarose gel electrophoresis. The DNA was transferred to a nylon membrane and analyzed with 32P-labeled DNA probes. For the northern blot analysis, freshly isolated RNA from mouse brain tissues was separated by agarose gel electrophoresis, transferred to a nylon membrane, and analyzed with 32P-labeled DNA probes. For the RT-PCR analysis, total RNA samples were extracted from mouse brains, using TRI-reagent (Sigma) according to the manufacturer's instructions. Aliquots of 1 or 2 μg RNA were used for reverse transcription (Omniscript RT, Qiagen) with oligo-dT priming. Primer information will be provided upon request. Western blot analysis For the western blot analysis, equal amounts of tissue extracts were separated by SDS-PAGE and transferred to PVDF membranes. Membranes were incubated with antibodies to Mib1 (gift from Dr. P. Gallagher) and β-actin (Sigma). Protein bands were detected by enhanced chemiluminescence (Amersham Pharmacia Biotech). Histology and Immunohistochemistry For histological analysis, tissues were fixed in 4% paraformaldehyde overnight at 4°C and embedded in paraffin wax or O.C.T. for sectioning. The sections were subjected to hematoxylin and eosin (H&E) or Nissle staining. For immunohistochemistry, paraffin-embedded or O.C.T.-embedded sections were used, and the antigenic epitopes were exposed using 10 mM citrate buffer and micro-waving. Sections were incubated in blocking solution (3% BSA, 5% goat serum or horse serum, and 0.5% Tween-20 in PBS) at RT for 4hr, followed by an additional incubation with various antibodies (Abs). Specific binding was detected with an ABC kit (Vectastain), an Envision kit (DAKO) or Alexa-488 (green) and/or -594 (red)-labeled Ab (Molecular Probes). Antibody probes included PECAM (1 200, MEC13.3, BD), CD44 (1 200, BD), αSMA (1 200, NeoMarker), K14 (1 1000, Covance), K10 (1 500, Covance), Loricrin (1 500, Covance), PCNA (1 200, Santa Cruz Biotechnology), Ki67 (1 200, Novocastra), NeuN (1 100, Chemicon), BLBP (1 2000, gift from Dr. N Heintz), and GFAP (1 3000, Dako).In situ hybridization and bone staining Details of the RNA in situ hybridizations on whole mount or sectioned embryos were described [13]. The ephrinB2, sm22, Fgf8, and Jag2 DIG-labeled (digoxigenin) riboprobes were generated from pGEM-T vectors (Promega) containing amplified cDNA fragments (about 700~800 bp). Staining patterns were confirmed by comparisons with previously published data. The bmp2 probe was kindly provided by M. Logan. For the skeletal analysis, following removal of the skin, the specimen was fixed overnight in ethanol, and stained with Alcian blue and Alizarin red. Figure S1 Generation of Mib1 conditional knockout mice. (A) Schematic drawing of the targeting strategy. The wild-type allele (wt) was recombined with the conditional targeting vector (tv) to generate the floxed allele (floxed). As a result, one loxP sequence and a loxP-neomycin cassette are inserted between exons 1 and 2 and exons 3 and 4 of the mouse Mib1 locus, respectively. Upon Cre expression, the floxed allele loses its exons 2 and 3 and becomes a null allele (deleted). Ev, EcoRV; H, HindIII; DTA, Diphtheria toxin A; neo, neomycin resistance gene. (B) The genomic Southern blot analyses by EcoRV (Ev) with a flanking probe and HindIII (H) with an internal probe show targeted embryonic stem cell clones (middle lane). (8.74 MB TIF) Click here for additional data file.(8.3M, tif) Acknowledgments The authors thank J. Lee and H. Hwang for technical supports in histology and M. Kong for animal husbandry and chimeric mice generation. Footnotes Competing Interests: The authors have declared that no competing interests exist. Funding: This research was supported by a grant (M103KV010021-06K2201-02110) from Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, the Republic of Korea. This work was also supported by (FG06-42-1) of the 21C Frontier Functional Human Genome Project from the Ministry of Science & Technology in Korea and the Vascular System Research center grant from the Korea Science and Engineering Foundation References 1. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284:770–776. [PubMed] 2. Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131:965–973. [PubMed] 3. Schweisguth F. Notch signaling activity. Curr Biol. 2004;14:R129–138. [PubMed] 4. Parks AL, Klueg KM, Stout JR, Muskavitch MA. Ligand endocytosis drives receptor dissociation and activation in the Notch pathway. Development. 2000;127:1373–1385. [PubMed] 5. Deblandre GA, Lai EC, Kintner C. Xenopus neuralized is a ubiquitin ligase that interacts with XDelta1 and regulates Notch signaling. Dev Cell. 2001;1:795–806. [PubMed] 6. Itoh M, Kim CH, Palardy G, Oda T, Jiang YJ, et al. Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell. 2003;4:67–82. [PubMed] 7. Lai EC, Deblandre GA, Kintner C, Rubin GM. Drosophila neuralized is a ubiquitin ligase that promotes the internalization and degradation of delta. Dev Cell. 2001;1:783–794. [PubMed] 8. Pavlopoulos E, Pitsouli C, Klueg KM, Muskavitch MA, Moschonas NK, et al. neuralized Encodes a peripheral membrane protein involved in delta signaling and endocytosis. Dev Cell. 2001;1:807–816. [PubMed] 9. Yeh E, Dermer M, Commisso C, Zhou L, McGlade CJ, et al. Neuralized functions as an E3 ubiquitin ligase during Drosophila development. Curr Biol. 2001;11:1675–1679. [PubMed] 10. Le Borgne R, Remaud S, Hamel S, Schweisguth F. Two distinct E3 ubiquitin ligases have complementary functions in the regulation of delta and serrate signaling in Drosophila. PLoS Biol. 2005;3:e96. [PubMed] 11. Lai EC, Roegiers F, Qin X, Jan YN, Rubin GM. The ubiquitin ligase Drosophila Mind bomb promotes Notch signaling by regulating the localization and activity of Serrate and Delta. Development. 2005;132:2319–2332. [PubMed] 12. Pitsouli C, Delidakis C. The interplay between DSL proteins and ubiquitin ligases in Notch signaling. Development. 2005;132:4041–4050. [PubMed] 13. Koo BK, Lim HS, Song R, Yoon MJ, Yoon KJ, et al. Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. Development. 2005;132:3459–3470. [PubMed] 14. Koo BK, Yoon KJ, Yoo KW, Lim HS, Song R, et al. Mind bomb-2 is an E3 ligase for Notch ligand. J Biol Chem. 2005;280:22335–22342. [PubMed] 15. Song R. Neuralized-2 regulates notch ligand in cooperation with mind bomb-1. J Biol Chem. 2006;281:36391–36400. [PubMed] 16. Ruan Y, Tecott L, Jiang MM, Jan LY, Jan YN. Ethanol hypersensitivity and olfactory discrimination defect in mice lacking a homolog of Drosophila neuralized. Proc Natl Acad Sci U S A. 2001;98:9907–9912. [PubMed] 17. Vollrath B, Pudney J, Asa S, Leder P, Fitzgerald K. Isolation of a murine homologue of the Drosophila neuralized gene, a gene required for axonemal integrity in spermatozoa and terminal maturation of the mammary gland. Mol Cell Biol. 2001;21:7481–7494. [PubMed] 18. Ladi E, Nichols JT, Ge W, Miyamoto A, Yao C, et al. The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands. J Cell Biol. 2005;170:983–992. [PubMed] 19. Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 2004;18:2474–2478. [PubMed] 20. Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci U S A. 2004;101:15949–15954. [PubMed] 21. Hozumi K, Negishi N, Suzuki D, Abe N, Sotomaru Y, et al. Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nat Immunol. 2004;5:638–644. [PubMed] 22. Estrach S, Ambler CA, Lo Celso C, Hozumi K, Watt FM. Jagged 1 is a beta-catenin target gene required for ectopic hair follicle formation in adult epidermis. Development. 2006;133:4427–4438. [PubMed] 23. Weller M, Krautler N, Mantei N, Suter U, Taylor V. Jagged1 ablation results in cerebellar granule cell migration defects and depletion of Bergmann glia. Dev Neurosci. 2006;28:70–80. [PubMed] 24. Jiang R, Lan Y, Chapman HD, Shawber C, Norton CR, et al. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev. 1998;12:1046–1057. [PubMed] 25. Sidow A, Bulotsky MS, Kerrebrock AW, Bronson RT, Daly MJ, et al. Serrate2 is disrupted in the mouse limb-development mutant syndactylism. Nature. 1997;389:722–725. [PubMed] 26. Commisso C, Boulianne GL. The NHR1 domain of Neuralized binds Delta and mediates Delta trafficking and Notch signaling. Mol Biol Cell. 2007;18:1–13. [PubMed] 27. Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 2004;18:2469–2473. [PubMed] 28. Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, et al. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med. 2001;193:741–754. [PubMed] 29. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999;13:295–306. [PubMed] 30. Wheatley SC, Isacke CM, Crossley PH. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development. 1993;119:295–306. [PubMed] 31. Pan Y, Lin MH, Tian X, Cheng HT, Gridley T, et al. gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis. Dev Cell. 2004;7:731–743. [PubMed] 32. Yamamoto N, Tanigaki K, Han H, Hiai H, Honjo T. Notch/RBP-J signaling regulates epidermis/hair fate determination of hair follicular stem cells. Curr Biol. 2003;13:333–338. [PubMed] 33. Sun X, Lewandoski M, Meyers EN, Liu YH, Maxson RE, Jr, et al. Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development. Nat Genet. 2000;25:83–86. [PubMed] 34. Klein AL, Zilian O, Suter U, Taylor V. Murine numb regulates granule cell maturation in the cerebellum. Dev Biol. 2004;266:161–177. [PubMed] 35. Lutolf S, Radtke F, Aguet M, Suter U, Taylor V. Notch1 is required for neuronal and glial differentiation in the cerebellum. Development. 2002;129:373–385. [PubMed] 36. Zhuo L, Theis M, Alvarez-Maya I, Brenner M, Willecke K, et al. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis. 2001;31:85–94. [PubMed] 37. Lind D, Franken S, Kappler J, Jankowski J, Schilling K. Characterization of the neuronal marker NeuN as a multiply phosphorylated antigen with discrete subcellular localization. J Neurosci Res. 2005;79:295–302. [PubMed] 38. Pan Y, Liu Z, Shen J, Kopan R. Notch1 and 2 cooperate in limb ectoderm to receive an early Jagged2 signal regulating interdigital apoptosis. Dev Biol. 2005;286:472–482. [PubMed] 39. Macias D, Ganan Y, Sampath TK, Piedra ME, Ros MA, et al. Role of BMP-2 and OP-1 (BMP-7) in programmed cell death and skeletogenesis during chick limb development. Development. 1997;124:1109–1117. [PubMed] 40. Zou H, Niswander L. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science. 1996;272:738–741. [PubMed] 41. Lai EC. Protein degradation: four E3s for the notch pathway. Curr Biol. 2002;12:R74–78. [PubMed] 42. Boulianne GL, de la Concha A, Campos-Ortega JA, Jan LY, Jan YN. The Drosophila neurogenic gene neuralized encodes a novel protein and is expressed in precursors of larval and adult neurons. Embo J. 1991;10:2975–2983. [PubMed] 43. Fitzgerald K, Greenwald I. Interchangeability of Caenorhabditis elegans DSL proteins and intrinsic signalling activity of their extracellular domains in vivo. Development. 1995;121:4275–4282. [PubMed] 44. Sun X, Artavanis-Tsakonas S. The intracellular deletions of Delta and Serrate define dominant negative forms of the Drosophila Notch ligands. Development. 1996;122:2465–2474. [PubMed] 45. Sun X, Artavanis-Tsakonas S. Secreted forms of DELTA and SERRATE define antagonists of Notch signaling in Drosophila. Development. 1997;124:3439–3448. [PubMed] 46. Zhang C, Li Q, Lim CH, Qiu X, Jiang YJ. The characterization of zebrafish antimorphic mib alleles reveals that Mib and Mind bomb-2 (Mib2) function redundantly. Dev Biol. 2007;305:14–27. [PubMed] 47. Barsi JC, Rajendra R, Wu JI, Artzt K. Mind bomb1 is a ubiquitin ligase essential for mouse embryonic development and Notch signaling. Mech Dev. 2005;122:1106–1117. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Science. 1999 Apr 30; 284(5415):770-6.
[Science. 1999]Development. 2004 Mar; 131(5):965-73.
[Development. 2004]Curr Biol. 2004 Feb 3; 14(3):R129-38.
[Curr Biol. 2004]Development. 2000 Apr; 127(7):1373-85.
[Development. 2000]Dev Cell. 2001 Dec; 1(6):795-806.
[Dev Cell. 2001]Curr Biol. 2001 Oct 30; 11(21):1675-9.
[Curr Biol. 2001]Dev Cell. 2003 Jan; 4(1):67-82.
[Dev Cell. 2003]PLoS Biol. 2005 Apr; 3(4):e96.
[PLoS Biol. 2005]PLoS Biol. 2005 Apr; 3(4):e96.
[PLoS Biol. 2005]Development. 2005 May; 132(10):2319-32.
[Development. 2005]Curr Biol. 2001 Oct 30; 11(21):1675-9.
[Curr Biol. 2001]Development. 2005 Sep; 132(18):4041-50.
[Development. 2005]Dev Cell. 2001 Dec; 1(6):795-806.
[Dev Cell. 2001]Dev Cell. 2003 Jan; 4(1):67-82.
[Dev Cell. 2003]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]J Biol Chem. 2006 Nov 24; 281(47):36391-400.
[J Biol Chem. 2006]J Biol Chem. 2005 Jun 10; 280(23):22335-42.
[J Biol Chem. 2005]J Cell Biol. 2005 Sep 12; 170(6):983-92.
[J Cell Biol. 2005]Genes Dev. 2004 Oct 15; 18(20):2474-8.
[Genes Dev. 2004]Nat Immunol. 2004 Jun; 5(6):638-44.
[Nat Immunol. 2004]Development. 2006 Nov; 133(22):4427-38.
[Development. 2006]Dev Neurosci. 2006; 28(1-2):70-80.
[Dev Neurosci. 2006]J Biol Chem. 2006 Nov 24; 281(47):36391-400.
[J Biol Chem. 2006]Mol Biol Cell. 2007 Jan; 18(1):1-13.
[Mol Biol Cell. 2007]Curr Biol. 2001 Oct 30; 11(21):1675-9.
[Curr Biol. 2001]J Biol Chem. 2006 Nov 24; 281(47):36391-400.
[J Biol Chem. 2006]Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9907-12.
[Proc Natl Acad Sci U S A. 2001]Mol Cell Biol. 2001 Nov; 21(21):7481-94.
[Mol Cell Biol. 2001]J Biol Chem. 2005 Jun 10; 280(23):22335-42.
[J Biol Chem. 2005]J Biol Chem. 2005 Jun 10; 280(23):22335-42.
[J Biol Chem. 2005]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]Genes Dev. 2004 Oct 15; 18(20):2474-8.
[Genes Dev. 2004]Proc Natl Acad Sci U S A. 2004 Nov 9; 101(45):15949-54.
[Proc Natl Acad Sci U S A. 2004]Genes Dev. 2004 Oct 15; 18(20):2469-73.
[Genes Dev. 2004]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]J Exp Med. 2001 Mar 19; 193(6):741-54.
[J Exp Med. 2001]Genes Dev. 1999 Feb 1; 13(3):295-306.
[Genes Dev. 1999]Development. 1993 Oct; 119(2):295-306.
[Development. 1993]Dev Cell. 2004 Nov; 7(5):731-43.
[Dev Cell. 2004]Curr Biol. 2003 Feb 18; 13(4):333-8.
[Curr Biol. 2003]Development. 2006 Nov; 133(22):4427-38.
[Development. 2006]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]J Biol Chem. 2005 Jun 10; 280(23):22335-42.
[J Biol Chem. 2005]Development. 2006 Nov; 133(22):4427-38.
[Development. 2006]Dev Cell. 2004 Nov; 7(5):731-43.
[Dev Cell. 2004]Curr Biol. 2003 Feb 18; 13(4):333-8.
[Curr Biol. 2003]Dev Neurosci. 2006; 28(1-2):70-80.
[Dev Neurosci. 2006]Dev Biol. 2004 Feb 1; 266(1):161-77.
[Dev Biol. 2004]Development. 2002 Jan; 129(2):373-85.
[Development. 2002]Genesis. 2001 Oct; 31(2):85-94.
[Genesis. 2001]J Neurosci Res. 2005 Feb 1; 79(3):295-302.
[J Neurosci Res. 2005]Dev Neurosci. 2006; 28(1-2):70-80.
[Dev Neurosci. 2006]Genes Dev. 1998 Apr 1; 12(7):1046-57.
[Genes Dev. 1998]Nature. 1997 Oct 16; 389(6652):722-5.
[Nature. 1997]Dev Biol. 2005 Oct 15; 286(2):472-82.
[Dev Biol. 2005]Genes Dev. 1998 Apr 1; 12(7):1046-57.
[Genes Dev. 1998]Nature. 1997 Oct 16; 389(6652):722-5.
[Nature. 1997]Dev Biol. 2005 Oct 15; 286(2):472-82.
[Dev Biol. 2005]Development. 1997 Mar; 124(6):1109-17.
[Development. 1997]Science. 1996 May 3; 272(5262):738-41.
[Science. 1996]Curr Biol. 2002 Jan 22; 12(2):R74-8.
[Curr Biol. 2002]Dev Cell. 2001 Dec; 1(6):795-806.
[Dev Cell. 2001]Dev Cell. 2001 Dec; 1(6):807-16.
[Dev Cell. 2001]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]PLoS Biol. 2005 Apr; 3(4):e96.
[PLoS Biol. 2005]Curr Biol. 2001 Oct 30; 11(21):1675-9.
[Curr Biol. 2001]PLoS Biol. 2005 Apr; 3(4):e96.
[PLoS Biol. 2005]Development. 2005 May; 132(10):2319-32.
[Development. 2005]EMBO J. 1991 Oct; 10(10):2975-83.
[EMBO J. 1991]J Biol Chem. 2006 Nov 24; 281(47):36391-400.
[J Biol Chem. 2006]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]J Biol Chem. 2006 Nov 24; 281(47):36391-400.
[J Biol Chem. 2006]Dev Cell. 2003 Jan; 4(1):67-82.
[Dev Cell. 2003]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]Development. 2006 Nov; 133(22):4427-38.
[Development. 2006]Dev Neurosci. 2006; 28(1-2):70-80.
[Dev Neurosci. 2006]Genes Dev. 1998 Apr 1; 12(7):1046-57.
[Genes Dev. 1998]Nature. 1997 Oct 16; 389(6652):722-5.
[Nature. 1997]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]Development. 1995 Dec; 121(12):4275-82.
[Development. 1995]Development. 1997 Sep; 124(17):3439-48.
[Development. 1997]Dev Cell. 2003 Jan; 4(1):67-82.
[Dev Cell. 2003]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]PLoS Biol. 2005 Apr; 3(4):e96.
[PLoS Biol. 2005]Development. 2005 Sep; 132(18):4041-50.
[Development. 2005]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9907-12.
[Proc Natl Acad Sci U S A. 2001]Mol Cell Biol. 2001 Nov; 21(21):7481-94.
[Mol Cell Biol. 2001]J Biol Chem. 2005 Jun 10; 280(23):22335-42.
[J Biol Chem. 2005]J Biol Chem. 2006 Nov 24; 281(47):36391-400.
[J Biol Chem. 2006]Dev Biol. 2007 May 1; 305(1):14-27.
[Dev Biol. 2007]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]Mech Dev. 2005 Oct; 122(10):1106-17.
[Mech Dev. 2005]Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9907-12.
[Proc Natl Acad Sci U S A. 2001]Development. 2005 Aug; 132(15):3459-70.
[Development. 2005]